Continuous Quantified EEG in NeuroIntensive Care (CrazyEEG)

September 21, 2023 updated by: Prof. Giuseppe Citerio, Azienda Ospedaliera San Gerardo di Monza

Utility of Continuous Electroencephalogram and Derived Variables in NeuroIntensive Care

To evaluate the ability of NICU (NeuroIntensive Care Unit) staff to interpret, before and after a training period, symmetry, sedation level, seizures activities and artefact on continuous cEEG/qEEG (continuous electroencephalography/quantitative electroencephalography) tracings.

Study Overview

Detailed Description

Using a web based tool, the clinicians of the two study centers will review 24 hours of recording (raw EEG data + derived qEEG variables).

The intensivists will evaluate:

  • simmetry,
  • sedation level,
  • seizures activities and
  • artefact on continuous cEEG/qEEG tracings. The same tracings will be blindly reviewed by a certified neurophysiologist (using the app). The neurophysiologist evaluation will be considered as "reference".

The results of the evaluation will be compared (intensivists vs. neurophysiologist) in order to understand if the intensivists are able to adequately identify the pathological findings.

The study period will be:

  • before a formal training
  • after a formal training by neurophysiologist in order to understand if the training is able to improve the intensivists performance.

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bergamo, Italy, 24100
        • Azienda Ospedaliera Papa Giovanni XXIII
      • Monza, Italy, 20052
        • Azienda Ospedaliera San Gerardo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Intensivists will evaluate tracing from patients in coma after a traumatic/vascular event admitted to neurointensive care and recorded with continuous EEG for clinical reasons

Description

Inclusion Criteria:

Intensivists wil evaluate daily qEEG recordings of:

  • Patients in coma after a traumatic/vascular event
  • Admitted to neurointensive care and
  • Recorded with continuous EEG for clinical reasons

Exclusion Criteria:

  • No EEG recording > 24 hours

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
qEEG patients
All the patients with continuous EEG (>24 hours) in the two study units

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Correct qEEG Evaluations
Time Frame: 2 months

Percentage of correct evaluation of qEEG tracings by intensivists vs. neurophysiologist.

The result will be expressed as percentage of correct evaluations for each domain.

2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Kappa Coefficient of Agreement Between Intensivists and Neurophysiologists After Training
Time Frame: 12 months

Comparison of the correct answers of the intensivist before and after a period of training.

Results will be expressed as coefficient of agreement between neurophysiologists and intensivists in interpretation of the tracings of continuous electroencephalography using Cohen's kappa coefficient, after training

12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Giuseppe Citerio, MD, Università Milano Bicocca

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2016

Primary Completion (Actual)

January 1, 2017

Study Completion (Actual)

January 1, 2017

Study Registration Dates

First Submitted

August 19, 2016

First Submitted That Met QC Criteria

September 9, 2016

First Posted (Estimated)

September 15, 2016

Study Record Updates

Last Update Posted (Actual)

March 22, 2024

Last Update Submitted That Met QC Criteria

September 21, 2023

Last Verified

September 1, 2023

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ischemic Stroke

3
Subscribe